Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ribosomal protein L3 pseudogene 1 (RPL3P1)
- Target
- RPL3P1
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL3P1 is a processed pseudogene in humans and mice, known as ribosomal protein L3 pseudogene 1[4]. Pseudogenes are non-functional segments of DNA that arise from functional genes but typically lack regulatory elements or have sequence changes that prevent normal expression or the production of a functional protein. RPL3P1 shares sequence similarity with the protein-coding *RPL3* gene, which encodes a core component of the ribosomal 60S large subunit. However, RPL3P1 itself does not produce a ribosomal protein or have a characterized molecular function. It is not classified as a receptor, enzyme, or therapeutic target. There are no known drugs, disease associations, or safety concerns related to RPL3P1, and it is not used as a biomarker.
- Other names
- RPL3PRPL3_8_1731RPL3-ps1Gm16468
02
Biological functions
Other (RPL3P1 does not have known biological function as a protein; as a pseudogene, it may potentially play regulatory roles, but none are established)
03
Disease associations
Other (No established direct roles in disease; not a protein, so not linked to canonical disease pathways)
Beyond the preview
Go deeper on ribosomal protein L3 pseudogene 1 (RPL3P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ribosomal protein L3 pseudogene 1 (RPL3P1).